Stem cell Transplantation

Track 16Stem cell Transplantation

Hematopoietic stem cell transplantation  is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood. It may be autologous the patient's own stem cells are used, allogeneic the stem cells come from a donor or syngeneic from an identical twin. It is a medical procedure in the field of hematology, most often performed for patients with certain cancers of the blood or bone marrow, such as multiple myeloma or leukemia. In these cases, the recipient's immune system is usually destroyed with radiation or chemotherapy before the transplantation. Infection and graft-versus-host disease are major complications of allogeneic .

Hematopoietic stem cell transplantation remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases. As survival following the procedure has increased, its use has expanded beyond cancer, such as autoimmune diseases and hereditary skeletal dysplasia’s notably malignant infantile osteoporosis and mucopolysaccharidosis.

  • Linking Race, Cancer Outcomes and Tissue Repair.
  • What is the role of apheresis technology in stem cell transplantation
  • Expanding transplantation of patients with a liver cancer without harming allocation

Related Conference of Stem cell Transplantation

October 30-30, 2020

Genetics and Molecular biology

Paris, France
November 16-17, 2020

International Conference on Genomics and Molecular Biology

Lisbon, Portugal
November 19-19, 2020

Webinar on Biotechnology

London, UK
November 23-24, 2020

International Conference on Toxicogenomics

Bali, Indonesia
December 07-08, 2020

2nd World Congress on Cell and Structural Biology

Sydney, Australia

Stem cell Transplantation Conference Speakers

Recommended Sessions

Related Journals

Are you interested in